192 related articles for article (PubMed ID: 22410553)
21. Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates.
Nork TM; Dubielzig RR; Christian BJ; Miller PE; Miller JM; Cao J; Zimmer EP; Wiegand SJ
Arch Ophthalmol; 2011 Aug; 129(8):1042-52. PubMed ID: 21825187
[TBL] [Abstract][Full Text] [Related]
22. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.
Suzuma K; Takagi H; Otani A; Oh H; Honda Y
Am J Pathol; 1999 Feb; 154(2):343-54. PubMed ID: 10027393
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
24. Time-lapse imaging of retinal angiogenesis reveals decreased development and progression of neovascular sprouting by anecortave desacetate.
Unoki N; Murakami T; Ogino K; Nukada M; Yoshimura N
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2347-55. PubMed ID: 19959648
[TBL] [Abstract][Full Text] [Related]
25. Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina.
Stitt AW; Graham D; Gardiner TA
Mol Vis; 2004 Jun; 10():432-8. PubMed ID: 15235573
[TBL] [Abstract][Full Text] [Related]
26. Fibulin-7 C-terminal fragment and its active synthetic peptide suppress choroidal and retinal neovascularization.
Ikeuchi T; Kanan Y; Long D; de Vega S; Hozumi K; Nomizu M; Campochiaro PA; Yamada Y
Microvasc Res; 2020 May; 129():103986. PubMed ID: 32017943
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1.
Shafiee A; Penn JS; Krutzsch HC; Inman JK; Roberts DD; Blake DA
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2378-88. PubMed ID: 10892887
[TBL] [Abstract][Full Text] [Related]
28. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
[TBL] [Abstract][Full Text] [Related]
29. Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier.
Paes KT; Wang E; Henze K; Vogel P; Read R; Suwanichkul A; Kirkpatrick LL; Potter D; Newhouse MM; Rice DS
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6452-61. PubMed ID: 21743011
[TBL] [Abstract][Full Text] [Related]
30. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization.
Zhang M; Yu D; Yang C; Xia Q; Li W; Liu B; Li H
Pharm Res; 2009 Jan; 26(1):204-10. PubMed ID: 18854954
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis inhibition by the maleimide-based small molecule GNX-686.
Nowak-Sliwinska P; Storto M; Cataudella T; Ballini JP; Gatz R; Giorgio M; van den Bergh H; Plyte S; Wagnières G
Microvasc Res; 2012 Mar; 83(2):105-10. PubMed ID: 22056402
[TBL] [Abstract][Full Text] [Related]
32. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
[TBL] [Abstract][Full Text] [Related]
33. Calcitriol is a potent inhibitor of retinal neovascularization.
Albert DM; Scheef EA; Wang S; Mehraein F; Darjatmoko SR; Sorenson CM; Sheibani N
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2327-34. PubMed ID: 17460298
[TBL] [Abstract][Full Text] [Related]
34. The influence of triamcinolone on endostatin-like proteins in oxygen-induced retinopathy of prematurity.
May CA
Exp Eye Res; 2012 Jul; 100():86-7. PubMed ID: 22609274
[TBL] [Abstract][Full Text] [Related]
35. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).
Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999
[TBL] [Abstract][Full Text] [Related]
37. CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
Franklin AJ; Jetton TL; Kuchemann CL; Russell SR; Kohn EC
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3756-66. PubMed ID: 15452087
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the mechanism of clearance of AMG 386, a selective angiopoietin-1/2 neutralizing peptibody, in splenectomized, nephrectomized, and FcRn knockout rodent models.
Wu B; Johnson J; Soto M; Ponce M; Calamba D; Sun YN
Pharm Res; 2012 Apr; 29(4):1057-65. PubMed ID: 22189693
[TBL] [Abstract][Full Text] [Related]
39. Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical administration.
Cloutier F; Lawrence M; Goody R; Lamoureux S; Al-Mahmood S; Colin S; Ferry A; Conduzorgues JP; Hadri A; Cursiefen C; Udaondo P; Viaud E; Thorin E; Chemtob S
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1195-203. PubMed ID: 22323484
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of claudins in retinas during normal development and the angiogenesis of oxygen-induced retinopathy.
Luo Y; Xiao W; Zhu X; Mao Y; Liu X; Chen X; Huang J; Tang S; Rizzolo LJ
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7556-64. PubMed ID: 21862644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
